Identification of hippocampus-related candidate genes for Alzheimer's disease

Annals of Neurology

Volumn 57, Issue 4, 2005, Pages 585-588

  Taguchi, Keiko ^a   Yamagata, Hidehisa D ^a   Zhong, Wangtao ^a   Kamino, Kouzin ^b   Akatsu, Hiroyasu ^c   Hata, Ryuji ^a   Yamamoto, Takayuki ^c   Kosaka, Kenji ^c   Takeda, Masatoshi ^b   Kondo, Ikuko ^a   Miki, Tetsuro ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HEREDITY; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALZHEIMER DISEASE; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; HUMANS; MALE; OCTAMER TRANSCRIPTION FACTOR-1; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTORS;

EID: 20144388360     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20433     Document Type: Article

References (16)

1. Kawas CH, Katzman R. The epidemiology of dementia and Alzheimer disease. In Terry RD, Katzman R, Bick KL, et al, eds. Alzheimer disease. Philadelphia: Lippincott Williams & Wilkins, 1999:95-116.
2. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001;81:741-766.
3. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
4. Bird TD, Sumi SM, Nemens EJ, et al. Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds. Ann Neurol 1989;25:12-25.
5. Campion D, Flaman JM, Brice A, et al. Mutations of the presenilin gene in families with early-onset Alzheimer's disease. Hum Mol Genet 1995;4:2373-2377.
6. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci U S A 1993;90:1977-1981.
7. van Duijn C, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994;7:74-78.
8. Houlden H, Crook R, Backhovens H, et al. ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families. Am J Med Genet 1998;81:117-121.
9. Erichsen HC, Chanock SJ. SNPs in cancer research and treatment. Br J Cancer 2004;90:747-751.
10. Hata R, Masumura M, Akatsu H, et al. Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. Biochem Biophys Res Commun 2001;284:310-316.
11. Folstein MF, Folstein SE, McHugh PR. Mini-Mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
12. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989:9-14.
13. Doris PA. Hypertension genetics, single nucleotide polymorphisms, and the common disease: common variant hypothesis. Hypertension 2002;39:323-331.
14. Ryan AK, Rosenfeld MG. POU domain family values: flexibility, partnerships, and developmental codes. Genes Dev 1997; 11:1207-1225.
15. Luchina NN, Krivega IV, Pankratova EV. Human Oct-1L isoform has tissue-specific expression pattern similar to Oct-2. Immunol Lett 2003;85:237-241.
16. Monsonego A, Weiner HL. Immunotherapeutic approaches to Alzheimer's disease. Science 2003;302:834-838.